Lexaria Bioscience (LEXX) Interest & Investment Income (2018 - 2026)

Lexaria Bioscience has reported Interest & Investment Income for 5 years, with the latest figure at $837.0 in Q2 2026.

• Quarterly Interest & Investment Income rose 340.53% year-over-year to $837.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $5434.0 (down 24.46% YoY) and the FY2025 annual result came in at $3017.0, down 78.92% from the prior year.
• Interest & Investment Income declined to $837.0 in Q2 2026 per LEXX's latest filing, from $1769.0 in the prior quarter.
• Over five years, Interest & Investment Income peaked at $7319.0 in Q4 2023 and troughed at $11.0 in Q4 2024.
• A 4-year average of $2493.4 and a median of $1303.0 in 2026 frame the typical range for Interest & Investment Income.
• The sharpest annual moves came in 2024 and 2026: Interest & Investment Income plunged 99.85% in 2024, then jumped 340.53% in 2026.
• Over 4 years, Interest & Investment Income stood at $7319.0 in 2023, then slumped by 99.85% to $11.0 in 2024, then increased by 9.09% to $12.0 in 2025, then jumped by 6875.0% to $837.0 in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $837.0, $1769.0, and $12.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.